CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Calcium patents expire, and when can generic versions of Calcium launch?
Calcium is a drug marketed by Amneal Pharms, Chartwell Rx, Heritage Pharms Inc, Hikma, Invagen Pharms, Lotus Pharm Co Ltd, Lupin Ltd, Nostrum Labs Inc, Square Pharms, Suven Pharms, Chartwell Molecular, Padagis Us, Am Regent, Intl Medication Sys, Medefil Inc, Hospira, Bausch, Abbott, Abraxis Pharm, Lilly, B Braun Medical Inc, Fresenius Kabi Usa, Nivagen Pharms Inc, Somerset, Amneal, and Hq Spclt Pharma. and is included in twenty-nine NDAs. There are two patents protecting this drug.
The generic ingredient in CALCIUM is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium
A generic version of CALCIUM was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALCIUM?
- What are the global sales for CALCIUM?
- What is Average Wholesale Price for CALCIUM?
Summary for CALCIUM
| US Patents: | 0 |
| Applicants: | 26 |
| NDAs: | 29 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CALCIUM |
| Drug Sales Revenues: | Drug sales revenues for CALCIUM |
| DailyMed Link: | CALCIUM at DailyMed |
US Patents and Regulatory Information for CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Spclt Pharma | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 210906-003 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Somerset | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 217689-001 | Oct 19, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 208418-003 | Jun 15, 2017 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 217689-002 | Oct 19, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nivagen Pharms Inc | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 213071-001 | Oct 14, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal Pharms | CALCIUM ACETATE | calcium acetate | CAPSULE;ORAL | 201658-001 | Oct 6, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER | calcium chloride | INJECTABLE;INJECTION | 021117-001 | Jan 28, 2000 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
